Searched for
INFOSYS MD
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Don't buy this dip, wait for the next one, says CA Rudramurthy BVIndian markets show a strong rebound, but expert CA Rudramurthy BV advises caution on fresh buying due to unfavorable risk-reward. He sugge...
- Raamdeo Agrawal, Radhakishan Damani, Motilal Oswal, Dolly Khanna: The superstar investors sitting out the NSE IPOWhile public sector entities like SBI cash in on decades-old NSE holdings for massive profits, prominent individual investors including Rad...
- Human-centric technology at heart of India's AI ambitions: PM Narendra Modi at Bharat Innovates 2026Prime Minister Narendra Modi emphasised India's "technology for humanity" approach at Bharat Innovates 2026 in Nice, aligning with India's ...
- IT needs selectivity, not blind bargain hunting; Energy, defence and healthcare offer better opportunities: Gurmeet ChadhaMarket expert Gurmeet Chadha advises investors to be selective in the IT sector, despite attractive valuations, focusing on stock-specific ...
- AI spooks IT valuations; Groww promoters cut stakeAI has pushed valuations of India’s top IT firms to 2008-09 levels. This and more in today’s ETtech Top 5.
- Infosys Q4 profit spikes; Flipkart mulls separate app for MinutesInfosys closed FY26 with strong numbers aided by a pickup in demand from its banking, energy and communication segments. This and more in...
- Infosys Q4 Results: Cons profit jumps 21% YoY to Rs 8,501 cr, revenue rises 13%; Rs 25/share dividend declaredInfosys Q4 Results: The company reported a 21% year-on-year rise in net profit to Rs 8,501 crore for Q4FY26, with revenue up 13.4% to Rs 46...
- Indian IT pack falls; MeitY’s e-gaming rulebookIndian IT stocks suffered on Wednesday after HCLTech’s weak Q4 numbers. This and more in today’s ETtech Top 5.
- Iran conflict and global risks slow GCC expansion in IndiaGlobal geopolitical tensions are slowing new technology centre openings in India, with a dip in brownfield expansions due to macro uncertai...
- Salil Parekh reappointed as Infosys CEO & MD for another five yearsParekh's new term is effective July 1, 2022 till March 31, 2027. Shareholder approval is being sought for the same, the company said.
- Finance Ministry summons Infosys CEO over glitches in IT e-filing portalThe Ministry of Finance has summoned Infosys MD and CEO, Salil Parekh on Monday over continuing glitches in the new income tax e-filing por...
- Infosys CFO Ranganath steps downThe Board at its meeting held today has accepted resignation of M. D. Ranganath as the CFO, Infosys said.
- Infosys shareholders approve appointment of Salil Parekh as CEO, MDAlso, 99.98 per cent Infosys shareholders approved appointment of UB Pravin Rao as chief operating officer and whole time director of the c...
- Infosys seeks shareholder nod to appoint Pravin Rao as MDHe will continue to hold the position of interim-CEO and MD for a maximum of five years, or until a new CEO and MD is appointed, Infosys sa...
- Infosys raises salary of CFO MD RanganathRanganath's compensation has been raised to $1.3 million with effect from July. That includes a fixed salary of $0.7 million and variable o...
- Infosys to relocate CFO to the US; revises his salary“The company has asked, for business reasons, MD Ranganath the CFO to operate from the US,” the company said in the filing. It did not elab...
- Infosys appoints D Sundaram as independent directorThe appointment is based on the recommendations of the Nomination and Remuneration Committee of the Board, Infosys said in a statement.
- R Seshasayee quits Ashok Leyland to focus more on role at InfosysThe reason for stepping down from Ashok Leyland is to focus more on his current responsibilities as the chairman of Infosys.
- Do not expect pricing decline to go away in the short term: MD Ranganath, Infosys"I think last year we said that 24-26% is our band and this year exactly we ended at midpoint 25%."
Load More
